{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2002"],"condition":["Neoplasm Metastasis","Chemotherapy","Colorectal Cancer","Colorectal Neoplasms","Metastatic Cancer"],"disease":["Neoplasm Metastasis","Chemotherapy","Colorectal Cancer","Colorectal Neoplasms","Metastatic Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2024620"],"location":["France"],"study_start_month":["7"],"keyword":["Folic Acid","Irinotecan","Stage IV rectal cancer","Oxaliplatin","Levoleucovorin","Resectable metastases","Leucovorin","Stage IV colon cancer","Adenocarcinoma of the colon","Adenocarcinoma of the rectum","Fluorouracil"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases","description":"PURPOSE: This randomized phase III trial is studying two different combination chemotherapy regimens to compare how well they work in treating patients with colorectal cancer and resectable metastases.","dates":{"creation":"2002-07-15"},"accession":"2024620","cross_references":{"ClinicalTrials___gov":["NCT00268398"]}}